Clements A, Johnston K, Mazzarelli J M, Ricciardi R P, Marmorstein R
The Wistar Institute, Department of Biochemistry and Biophysics, University of Pennsylvania Dental School, and The Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Biochemistry. 2000 Dec 26;39(51):16033-45. doi: 10.1021/bi002111g.
Human papillomavirus 16 E7 (HPV16 E7) and adenovirus 5 E1A (Ad5 E1A) are encoded by highly divergent viruses yet are functionally similar in their ability to bind the retinoblastoma (pRB) tumor suppressor protein, causing the aberrant displacement of E2F trancription factors. The amino acid residues of HPV16 E7 that are necessary for stability, for inhibition of pRB function, and for cell transformation are also necessary for E7 oligomerization. However, neither the specific oligomerization state of HPV16 E7 nor of Ad5 E1A as a function of pRB-binding has been characterized. To gain insight into HPV16 E7 and Ad5 E1A oligomerization properties, sedimentation equilibrium experiments were performed with recombinant HPV16 E7 and Ad5 E1A proteins. These studies reveal that, despite the overall functional similarities between these proteins, monomers, dimers, and tetramers of HPV16 E7 were detected while only reversible monomer-dimer association was identified for Ad5 E1A. The apparent K(d(monomer)-(dimer)) of HPV16 E7 is approximately 100-fold lower than that of a comparable region of Ad5 E1A, and it is concluded that under physiological protein concentrations HPV16 E7 exists primarily as a dimer. Sedimentation equilibrium experiments of pRB/Ad5 E1A and of pRB/HPV16 E7 complexes demonstrate that the tight association of pRB with the viral oncoproteins does not disturb their inherent oligomerization properties. Taken together, this study demonstrates significant differences between the Ad5 E1A and HPV16 E7 oligomerization states that are potentially related to their distinct structures and specific mechanisms of pRB-inactivation.
人乳头瘤病毒16 E7(HPV16 E7)和腺病毒5 E1A(Ad5 E1A)由高度不同的病毒编码,但在结合视网膜母细胞瘤(pRB)肿瘤抑制蛋白的能力方面功能相似,导致E2F转录因子发生异常移位。HPV16 E7中对于稳定性、抑制pRB功能以及细胞转化所必需的氨基酸残基,对于E7寡聚化也是必需的。然而,HPV16 E7以及Ad5 E1A作为pRB结合功能的特定寡聚化状态均未得到表征。为深入了解HPV16 E7和Ad5 E1A的寡聚化特性,对重组HPV16 E7和Ad5 E1A蛋白进行了沉降平衡实验。这些研究表明,尽管这些蛋白在整体功能上具有相似性,但检测到HPV16 E7的单体、二聚体和四聚体,而对于Ad5 E1A仅鉴定出可逆的单体 - 二聚体缔合。HPV16 E7的表观K(d(单体)-(二聚体))比Ad5 E1A的可比区域低约100倍,并且得出结论,在生理蛋白浓度下HPV16 E7主要以二聚体形式存在。pRB/Ad5 E1A和pRB/HPV16 E7复合物的沉降平衡实验表明,pRB与病毒癌蛋白的紧密结合不会干扰它们固有的寡聚化特性。综上所述,本研究证明了Ad5 E1A和HPV16 E7寡聚化状态之间存在显著差异,这可能与它们不同的结构以及pRB失活的特定机制有关。